June 2020

12
Jun

Biofortuna appointed as CMO for QuantuMDx CE–marked assay

Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.